Skip to main content
SpringerLink
Log in

Statins: reporting rates for muscle-related ADRs differ substantially

  • Incidence study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Hoffman KB, Kraus C, Dimbil M, Golomb BA.A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class. PLoS One 7: e42866, No. 8, 22 Aug 2012. Available from: URL: http://dx.doi.org/10.1371/journal.pone.0042866

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Statins: reporting rates for muscle-related ADRs differ substantially. React. Wkly. 1418, 4 (2012). https://doi.org/10.2165/00128415-201214180-00014

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214180-00014

Keywords

Search

Navigation